Analisis Hubungan Kualitas Hidup Dan Biaya Medis Langsung Pada Pasien Penyakit Ginjal Kronik : Studi Observasional Di Rumah Sakit Pendidikan

Penulis

  • Sinthia Aas Sumantika Sari Program Studi Sarjana Farmasi, Universitas Almarisah Madani, Makassar, Indonesia
  • Fajriansyah Bagian Farmakologi dan Farmasi Klinik, Universitas Almarisah Madani, Makassar, Indonesia https://orcid.org/0000-0002-3636-9470

DOI:

https://doi.org/10.32382/mf.v22i1.1778

Kata Kunci:

penyakit ginjal kronik, kualitas hidup, EQ-5D-5L, biaya medis langsung

Abstrak

Analysis of the Association Between Quality of Life and Direct Medical Costs in Patients with Chronic Kidney Disease: An Observational Study in a Teaching Hospital

Chronic kidney disease (CKD) is a chronic condition that significantly affects patients’ quality of life and imposes a substantial burden on healthcare costs. This study aimed to analyze the quality of life and direct medical costs among hospitalized CKD patients and to explore the association between these variables. This was a prospective observational study with a descriptive-analytic approach conducted at Universitas Hasanuddin Hospital from May to July 2025. Quality of life data were collected using the Indonesian versions of the EQ-5D-5L instrument and the EQ visual analogue scale (EQ-VAS), while direct medical cost data were obtained from the hospital billing system. A total of 26 patients meeting the inclusion criteria were enrolled. Data were analyzed using univariate, bivariate, and Spearman correlation tests with a significance level of p < 0.05. The results showed that the mean EQ-5D-5L index was 0.435 ± 0.43 and the mean EQ-VAS score was 63.5 ± 16.9. Significant differences in quality of life were observed based on age (p = 0.032), sex (p = 0.041), and comorbidities (p = 0.018). The mean direct medical cost was IDR 61,013,182 per patient per hospitalization episode, with the largest components attributed to medication and laboratory examination costs. A significant negative correlation was found between quality of life and direct medical costs (r = −0.412; p = 0.036). In conclusion, the quality of life among hospitalized CKD patients tends to be low and is significantly associated with increased direct medical costs.

Penyakit ginjal kronik (chronic kidney disease/CKD) merupakan penyakit kronis yang berdampak signifikan terhadap kualitas hidup pasien dan beban biaya pelayanan kesehatan. Penelitian ini bertujuan untuk menganalisis kualitas hidup dan biaya medis langsung pasien rawat inap CKD serta mengeksplorasi hubungan antara keduanya. Penelitian ini merupakan studi observasional prospektif dengan pendekatan deskriptif-analitik yang dilakukan di Rumah Sakit Universitas Hasanuddin pada periode Mei–Juli 2025. Data kualitas hidup diperoleh menggunakan instrumen EQ-5D-5L versi Bahasa Indonesia dan EQ-VAS, sedangkan data biaya medis langsung diperoleh dari sistem billing rumah sakit. Sampel penelitian sebanyak 26 pasien yang memenuhi kriteria inklusi. Analisis data dilakukan secara univariat, bivariat, dan korelasi spearman dengan tingkat signifikansi p<0,05. Hasil penelitian menunjukkan bahwa rerata indeks EQ-5D-5L sebesar 0,435±0,43 dan skor EQ-VAS sebesar 63,5±16,9. Terdapat perbedaan signifikan kualitas hidup berdasarkan usia (p=0,032), jenis kelamin (p=0,041), dan komorbiditas (p=0,018). Rerata biaya medis langsung sebesar Rp. 61.013.182 per pasien per episode rawat inap, dengan komponen terbesar berasal dari biaya obat dan pemeriksaan laboratorium. Terdapat hubungan negatif yang signifikan antara kualitas hidup dan biaya medis langsung (r=-0,412; p=0,036). Disimpulkan bahwa kualitas hidup pasien CKD rawat inap cenderung rendah dan berhubungan dengan peningkatan biaya medis langsung.

Referensi

Stevens PE, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, et al. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International. 2024;105(4, Supplement):S117–314. doi:https://doi.org/10.1016/j.kint.2023.10.018

Webster AC, Nagler E V, Morton RL, Masson P. Chronic Kidney Disease. The Lancet. 2017;389(10075):1238–52. doi:https://doi.org/10.1016/S0140-6736(16)32064-5

Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet. 2020 Feb 29;395(10225):709–33. doi:10.1016/S0140-6736(20)30045-3

Riskesdas. Laporan Riskesdas 2018 Nasional.pdf. Lembaga Penerbit Balitbangkes. 2018.

Nair D, Wilson FP. Patient-Reported Outcome Measures for Adults With Kidney Disease: Current Measures, Ongoing Initiatives, and Future Opportunities for Incorporation Into Patient-Centered Kidney Care. American Journal of Kidney Diseases. 2019;74(6):791–802. doi:https://doi.org/10.1053/j.ajkd.2019.05.025

Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the Kidney Disease Quality of Life (KDQOLTM) Instrument. Quality of Life Research. 1994;3(5):329–38. doi:10.1007/BF00451725

Honeycutt AA, Segel JE, Zhuo X, Hoerger TJ, Imai K, Williams D. Medical costs of CKD in the Medicare population. Journal of the American Society of Nephrology : JASN. 2013 Sep;24(9):1478–83. doi:10.1681/ASN.2012040392 PubMed PMID: 23907508.

Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. The Lancet. 2015 May 16;385(9981):1975–82. doi:10.1016/S0140-6736(14)61601-9

Vanholder R, Annemans L, Brown E, Gansevoort R, Gout-Zwart JJ, Lameire N, et al. Reducing the costs of chronic kidney disease while delivering quality health care: a call to action. Nature Reviews Nephrology. 2017;13(7):393–409. doi:10.1038/nrneph.2017.63

Nappoe SA, Djasri H, Kurniawan MF. Chronic disease management programme (PROLANIS) in Indonesia: Case study. Iris.Who.Int. 2023. 1–62 p.

Walker RC, Hanson CS, Palmer SC, Howard K, Morton RL, Marshall MR, et al. Patient and Caregiver Perspectives on Home Hemodialysis: A Systematic Review. American Journal of Kidney Diseases. 2015 Mar 1;65(3):451–63. doi:10.1053/j.ajkd.2014.10.020

Busse R, Geissler A, Aaviksoo A, Cots F, Häkkinen U KC. Diagnosis related groups in Europe : moving towards transparency , efficiency , and quality in hospitals ? BMJ Quality & Safety. 2013;3197(June):1–7. doi:10.1136/bmj.f3197

Soetedja S, Nurwahyuni A, Intan A. Biaya Pelayanan Hemodialisis Pasien Gagal Ginjal Kronis di Era JKN : Literature Review: Cost of Hemodialysis for Chronic Renal Failure Patients in The Era of UHC : Literature Review. Media Publikasi Promosi Kesehatan Indonesia (MPPKI). 2022 Oct 4;5:1213–8. doi:10.56338/mppki.v5i10.2712

Wyld M, Morton RL, Hayen A, Howard K, Webster AC. A Systematic Review and Meta-Analysis of Utility-Based Quality of Life in Chronic Kidney Disease Treatments. PLOS Medicine. 2012 Sep 11;9(9):e1001307.

Erickson KF, Zhao B, Ho V, Winkelmayer WC. Employment among Patients Starting Dialysis in the United States. Clinical journal of the American Society of Nephrology : CJASN. 2018 Feb;13(2):265–73. doi:10.2215/CJN.06470617 PubMed PMID: 29348264.

Tasnim T, Karim KMR, Rahman T, Rashid HU. Health-related quality of life and its predictors among chronic kidney disease patients: A hospital-based cross-sectional study. PloS one. 2025;20(2):e0319100. doi:10.1371/journal.pone.0319100 PubMed PMID: 39919056.

Pagels AA, Söderkvist BK, Medin C, Hylander B, Heiwe S. Health-related quality of life in different stages of chronic kidney disease and at initiation of dialysis treatment. Health and quality of life outcomes. 2012 Jun;10:71. doi:10.1186/1477-7525-10-71 PubMed PMID: 22710013.

EuroQol Research Foundation. EQ-5D-5L-Userguide-2025. Rotterdam; 2025.

Cohen J. A Power Primer. Psychological Bulletin. 1992 Jul 1;112:155–9. doi:10.1037/0033-2909.112.1.155

Tonelli M, Wiebe N, Manns B, Klarenbach S, James M, Ravani P, et al. Comparison of the Complexity of Patients Seen by Different Medical Subspecialists in a Universal Health Care System. JAMA Network Open. 2018 Nov 30;1:e184852. doi:10.1001/jamanetworkopen.2018.4852

Fauziah F, Kusuma IY, Aisya Putri B, Indah Kurniasih K, Agung Nugroho G, Nurkholis F. Cost Analysis of Haemodialysis in Chronic Kidney Disease: The Role of Patient Characteristics in a Regional Indonesian Hospital. Jurnal Sains Farmasi & Klinis. 2026 Mar 7;12(3 SE-Research Articles):192–8. doi:10.25077/jsfk.12.3.192-198.2025

Sunariyanti E, Andayani TM, Endarti D, Puspandari DA. Cost Analysis of Chronic Kidney Disease Patients in Indonesia. ClinicoEconomics and outcomes research : CEOR. 2023;15:621–9. doi:10.2147/CEOR.S388547 PubMed PMID: 37533797.

Unduhan

Diterbitkan

30-04-2026

Cara Mengutip

Sinthia Aas Sumantika Sari, & Fajriansyah. (2026). Analisis Hubungan Kualitas Hidup Dan Biaya Medis Langsung Pada Pasien Penyakit Ginjal Kronik : Studi Observasional Di Rumah Sakit Pendidikan. Media Farmasi, 22(1), 1–8. https://doi.org/10.32382/mf.v22i1.1778

Terbitan

Bagian

Media Farmasi Edisi April 2026